MNU-treated WT mice exhibited globoid dysplasia and well- and poorly differentiated carcinoma, whereas MNU-treated PGC KO mice showed adenoma, regenerative and globoid dysplasia, and well- and moderately differentiated adenocarcinoma (Fig. 3C). The gene discussed is PGC; the disease is adenoma.